Electra Therapeutics, Inc.

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Certification of approval for listing and registration on a national securities exchange

Registration of Securities on Exchange

Prospectus Supplement with Pricing Information

Notice of Effectiveness

No description available

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission)

Rule 506(b) provides a "safer harbor" for a private offering

GORDON CARL L

ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC

Koe Gary S.

Westlake BioPartners Fund I, L.P.; Westlake BioPartners Fund II, L.P.; Westlake BioPartners GP II, LLC; Westlake BioPartners GP I, LLC

Parry Graham

Stagliano Nancy

Dong Quehuong (Kathy)

ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC

Koe Gary S.

Dao Kim-Hien

Dong Quehuong (Kathy)

Tucker David J.

Parry Graham

Parry Graham

GORDON CARL L

Fust Matthew K

Stagliano Nancy